Vaccinex raises $3.8M via private placement of 7.14M shares at $0.5293 per share

VACCINEX, INC.

Issued 7,142,496 shares to accredited investors for gross proceeds of ~$3.8 million.
Insider participation: CEO Maurice Zauderer, chairman Albert Friedberg, directors Jacob Frieberg and Gerald Van Strydonck.
Proceeds to fund pepinemab clinical trials and for working capital.
Registration rights agreement filed to register shares for resale within 75 days after closing.
Shares sold under Section 4(a)(2) and Rule 506 of Regulation D.

item 1.01 item 3.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

VACCINEX, INC. entered into Registration Rights Agreement with certain of the Investors (effective 2022-11-22).

Action: entry
Agreement: equity purchase
Counterparty: certain of the Investors
Effective: 2022-11-22

Exact text from the filing

On November 22, 2022, the Company entered into a registration rights agreement (the “Registration Rights Agreement”) with certain of the Investors that affords such Investors certain registration rights with respect to the Shares.

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

VACCINEX, INC. entered into Stock Purchase Agreement with the investors named therein valued at approximately $3.8 million (effective 2022-11-18).

Action: entry
Agreement: equity purchase
Counterparty: the investors named therein
Value: approximately $3.8 million
Effective: 2022-11-18

Exact text from the filing

On November 18, 2022, Vaccinex, Inc. (the “Company”) entered into a stock purchase agreement (the “Stock Purchase Agreement”) pursuant to which the Company agreed to issue and sell to the investors named therein an aggregate of 6,112,031 shares of common stock, par value $0.0001 per share, of the Company (the “Common Stock”), at a purchase price of $0.5293 per Share.

View on SEC.gov

Browse all material agreements →

VACCINEX, INC. filing history →

Source: SEC EDGAR

accession 0001193125-22-292625

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.